Statistical Science

A conversation with Tavia Gordon

Nancy L. Geller

Full-text: Open access


Tavia Gordon was born on December 14, 1917, in Chicago, Illinois. He received a B.A. degree in anthropology from the University of California in 1938. He did graduate work in anthropology at the University of Chicago in 1938-1939, in mathematics at the University of Southern California in 1947-1948, and in mathematical statistics at the University of California, Berkeley, in 1948-1950. He is a Fellow of the American Statistical Association and the Council on Epidemiology, American Heart Association. His tenure at NIH included the years 1954-1960 and 1966-1977, beginning as an Analytical Statistician with the Biometrics Research Section of the National Heart Institute. He spent the next two years at the Biometry Branch at the National Cancer Institute. His last 10 years at NIH were spent at the National Heart, Lung and Blood Institute. During this period he was heavily involved in the development of the design and analysis of the first long-term, large-scale community-based follow-up study in the United States, the Framingham Study. He was awarded the NIH Director's Award in 1977. Since leaving the National Institutes of Health, he has been a consulting statistician, a senior scientist for General Electric Corporation and, since 1981, a Research Professor at George Washington University Biostatistics Center.

Article information

Statist. Sci., Volume 12, Number 2 (1997), 113-118.

First available in Project Euclid: 21 August 2002

Permanent link to this document

Digital Object Identifier


Geller, Nancy L. A conversation with Tavia Gordon. Statist. Sci. 12 (1997), no. 2, 113--118. doi:10.1214/ss/1029963428.

Export citation


  • [1] Cornfield, J., Gordon, T. and Smith, W. S. (1961). Quantal response curves for experimentally uncontrolled variables. Bulletin of the International Statistical Institute 38 97-115.
  • [2] Cornfield, J., Halperin, M. and Moore, F. (1956). Safety testing of the Salk poliomy elitis vaccine. Public Health Reports 71 1045-1056.
  • [3] Dawber, T. R., Moore, F. E. and Mann, G. V. (1957). Coronary heart disease in the Framingham study. American Journal of Public Health 47 4-24.
  • [4] DeMets, D. and Halperin, M. (1977). Estimation of a simple regression coefficient in samples arising from a subsampling procedure. Biometrics 33 47-56.
  • [5] Gordon, T. (1970). The Framingham Diet Study: diet and the regulation of serum cholesterol. In The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 24. U.S. Government Printing Office, Washington, D.C.
  • [6] Gordon, T., Moore, F. E., Shurtleff, D. and Dawber,
  • T. R. (1959). Some methodologic problems in the longterm study of cardiovascular disease: observations on the Framingham study. Journal of Chronic Diseases 10 186- 206.
  • [7] Greenhouse, S. W. (1997). Some reflections on the beginnings and developments of statistics in "Your father's NIH." Statist. Sci. 12 81-85.
  • [8] Halperin, M. G., Kjelsberg, M., Neaton, J. and Sherwin,
  • R. (1977). Statistical design considerations in the NHLBI Multiple Risk Factor Intervention Trial (MRFIT). Journal of Chronic Diseases 30 320-330.
  • [9] Lewis, L. A., Olmsted, F., Page, I. H., Lawry, E. Y., Mann, G. V., Stare, F. J., Hanig, M., Lauffer, M. A., Gordon,
  • T. and Moore, F. E. (1957). Serum lipid levels in normal persons: findings of a cooperative study of lipoprotein and atherosclerosis. Circulation 16 227-245.
  • [10] Mantel, N. (1973). Sy nthetic retrospective studies and related topics. Biometrics 29 479-486.
  • [11] Mantel, N., Brown, C. and By ar, D. P. (1977). Tests for homogeneity of effect in an epidemiologic investigation. American Journal of Epidemiology 106 125-129.
  • [12] Technical Group and Committee on Lipoprotein and Ath
  • erosclerosis (1956). Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation 14 691-742.
  • [13] (1960). The evolution of rheumatic heart disease in children. Five-year report of a co-operative clinical trial of
  • ACTH, cortisone, and aspirin. Circulation 22 503-515.